炎症体
尼日利亚霉素
化学
查尔酮
立体化学
半胱氨酸蛋白酶1
抑制性突触后电位
目标2
作用机理
IC50型
生物化学
体外
生物
受体
神经科学
膜
作者
Xu Ma,Min Zhao,Minghai Tang,Linlin Xue,Ruijia Zhang,Ling Liu,Hengfan Ni,Xiaoying Cai,Shuang Yuan Kuang,Feng Hong,Lun Wang,Kai Chen,Huan Tang,Yan Li,Aihua Peng,Jianhong Yang,Heying Pei,Hao-Yu Ye,Lijuan Chen
标识
DOI:10.1021/acs.jnatprod.0c00478
摘要
Eight new flavonoids, including two β-hydroxy/methoxychalcones, velutones A and B (1 and 2), two 1,3-diarylpropan-1-ols, velutols C and D (3 and 4), a dihydroxychalcone, velutone E (5), a chalcone, velutone F (6), a furanoflavanone, velutone G (7), and a furanoflavonol, velutone H (8), and 14 known compounds were isolated from Millettia velutina. Their structures were determined by high-resolution electrospray ionisation mass spectrometry (HR-ESIMS) and spectroscopic data analyses and time-dependent density functional theory electronic circular dichroism (TD-DFT–ECD) calculations. Among the isolated constituents, compound 6 exhibited the most potent inhibitory effect (IC50: 1.3 μM) against nigericin-induced IL-1β release in THP-1 cells. The initial mechanism of action study revealed that compound 6 suppressed NLRP3 inflammasome activation via blocking ASC oligomerization without affecting the priming step, which subsequently inhibited caspase-1 activation and IL-1β secretion. Most importantly, compound 6 exerted potent protective effects in the LPS-induced septic shock mice model by improving the survival rate of mice and suppressing serum IL-1β release. These results demonstrated that compound 6 had the potential to be developed as a broad-spectrum NLRP3 inflammasome inhibitor for the treatment of NLRP3-related disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI